# LETYBO

NDC: 81165-050
Generic name: letibotulinumtoxinA-wlbg
Labeler / Manufacturer: Hugel, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAMUSCULAR
Marketing started: 20240730

FDA application: BLA761225

## Active ingredients

- LETIBOTULINUMTOXINA: 50 U/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"81165-050"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=81165-050
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=910e5d0e-4d0b-4de8-8e2d-97879a044181